Great Hill’s Quantum Health awaits final bids

Quantum is bigger and more profitable than its competitor Accolade – whose performance in the public markets has only accelerated PE interest in the Great Hill-backed business.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this